loader
Please Wait
Applying Filters...
menu
    • menu

    Information, Expiry & Status of Health Canada Patents covering Degarelix Acetate.

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Degarelix Acetate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 291,617Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2Ferring Inc.

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Ferring Inc.

    Degarelix Acetate
    arrow
    Discovery on Target
    Not Confirmed

    Ferring Inc.

    Switzerland
    arrow
    Discovery on Target
    Not Confirmed

    Patent Expiration Date : 2018-04-13

    Date Granted : 2007-01-09

    Degarelix Acetate

    Brand Name : FIRMAGON

    Patent Number : 2286190

    Filing Date : 1998-04-13

    Strength per Unit : 120 mg (40 mg / mL)

    Dosage Form : Powder and solvent for suspension for injection

    Human Or VET : Human

    Route of Administration : Subcutaneous Injection

    Patent Expiration Date : 2018-04-13

    Date Granted : 2007-01-09

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Ferring Inc.

    Degarelix Acetate
    arrow
    Discovery on Target
    Not Confirmed

    Ferring Inc.

    Switzerland
    arrow
    Discovery on Target
    Not Confirmed

    Patent Expiration Date : 2018-04-13

    Date Granted : 2007-01-09

    Degarelix Acetate

    Brand Name : FIRMAGON

    Patent Number : 2286190

    Filing Date : 1998-04-13

    Strength per Unit : 80 mg (20 mg / ml)

    Dosage Form : Powder and solvent for supension for injection

    Human Or VET : Human

    Route of Administration : Subcutaneous Injection

    Patent Expiration Date : 2018-04-13

    Date Granted : 2007-01-09

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF